In type 2 diabetes, hyperglycaemia can arise from different processes, ranging from insulin deficiency (in individuals with relative insulin sensitivity) to severe insulin resistance and hyperinsulinaemia; clinical presentations also vary greatly with respect to disease severity, risk of complications and response to therapy [3, 4]. This evidence concerns the gene INS and type 2 diabetes mellitus.